Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey
Authors:
Open Access
- 28 April 2017
- journal article
- research article
- Published by Springer Nature in Chinese Journal of Cancer
- Vol. 36 (1) , 1-15
Abstract
The increasing prevalence of colorectal cancer (CRC) in China and the paucity of information about relevant expenditure highlight the necessity of better understanding the financial burden and effect of CRC diagnosis and treatment. We performed a survey to quantify the direct medical and non-medical expenditure as well as the resulting financial burden of CRC patients in China. We conducted a multicenter, cross-sectional survey in 37 tertiary hospitals in 13 provinces across China between 2012 and 2014. Each enrolled patient was interviewed using a structured questionnaire. All expenditure data were inflated to the 2014 Chinese Yuan (CNY; 1 CNY = 0.163 USD). We quantified the overall expenditure and financial burden and by subgroup (hospital type, age at diagnosis, sex, education, occupation, insurance type, household income, clinical stage, pathologic type, and therapeutic regimen). We then performed generalized linear modeling to determine the factors associated with overall expenditure. A total of 2356 patients with a mean age of 57.4 years were included, 57.1% of whom were men; 13.9% of patients had stage I cancer; and the average previous-year household income was 54,525 CNY. The overall average direct expenditure per patient was estimated to be 67,408 CNY, and the expenditures for stage I, II, III, and IV disease were 56,099 CNY, 59,952 CNY, 67,292 CNY, and 82,729 CNY, respectively. Non-medical expenditure accounted for 8.3% of the overall expenditure. The 1-year out-of-pocket expenditure of a newly diagnosed patient was 32,649 CNY, which accounted for 59.9% of their previous-year household income and caused 75.0% of families to suffer an unmanageable financial burden. Univariate analysis showed that financial burden and overall expenditure differed in almost all subgroups (P < 0.05), except for sex. Multivariate analysis showed that patients who were treated in specialized hospitals and those who were diagnosed with adenocarcinoma or diagnosed at a later stage were likely to spend more, whereas those with a lower household income and those who underwent surgery spent less (all P < 0.05). For patients in China, direct expenditure for the diagnosis and treatment of CRC seemed catastrophic, and non-medical expenditure was non-ignorable. The financial burden varied among subgroups, especially among patients with different clinical stages of disease, which suggests that, in China, CRC screening might be cost-effective.Keywords
Funding Information
- National Natural Science Foundation of China (81402740)
- Specialized Research Fund for the Doctoral Program of Higher Education (20131106120014)
- Beijing hope run special fund (# LC2012YF44)
- The National Health and Family Planning Committee of P. R. China
This publication has 28 references indexed in Scilit:
- Physical, Psychosocial, Relationship, and Economic Burden of Caring for People With Cancer: A ReviewJournal of Oncology Practice, 2013
- New pathways of care for cancer survivors: adding the numbersBritish Journal of Cancer, 2011
- Delivering affordable cancer care in high-income countriesThe Lancet Oncology, 2011
- Symptom burden in cancer survivors 1 year after diagnosisCancer, 2011
- Economic Burden for Informal Caregivers of Lung and Colorectal Cancer PatientsThe Oncologist, 2010
- Parental cancer and the familyCancer, 2010
- How Much ‘Skin In The Game’ Do Medicare Beneficiaries Have? The Increasing Financial Burden Of Health Care Spending, 1997–2003Health Affairs, 2007
- Protecting Households From Catastrophic Health SpendingHealth Affairs, 2007
- Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: A population based studyEuropean Journal of Cancer, 2006
- Financial and family burden associated with cancer treatment in Ontario, CanadaSupportive Care in Cancer, 2006